Previous studies have investigated the role of inflammation-based risk scores/ratios in advanced or metastatic NEN, noting the prognostic role of increased CRP and white blood cell counts, reflecting an inflamed tumor microenvironment [56]. This evidence concerns the gene CRP and neoplasm.